Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.43 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.42 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.41 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9703679 | 0.92 | POLB (0.46) | — | |
| SCHEMBL9295059 | 0.92 | POLB (0.46) | — | |
| SCHEMBL18927158 | 0.92 | POLB (0.46) | — | |
| SCHEMBL17860572 | 0.92 | POLB (0.46) | — | |
| SCHEMBL24823137 | 0.92 | P2RY12 (0.42) | P2RY12P2RY1PRMT6P2RY2P2RY6 | |
| SCHEMBL31195761 | 0.92 | P2RY12 (0.42) | P2RY12P2RY1PRMT6P2RY2P2RY6 | |
| SCHEMBL9155270 | 0.91 | PRMT6 (0.45) | P2RY12P2RY1PRMT6 | |
| SCHEMBL9155260 | 0.91 | PRMT6 (0.45) | P2RY12P2RY1PRMT6 | |
| SCHEMBL29461518 | 0.91 | P2RY12 (0.48) | P2RY12P2RY1P2RY2P2RY6 | |
| SCHEMBL3822223 | 0.91 | P2RY12 (0.48) | P2RY12P2RY1P2RY2P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111748550-B | Method for labeling nucleic acid | 国立大学法人九州大学 | 2023-11-24 | — | — | CN | disclosed |
| US-11499178-B2 | Labeling method for nucleic acid | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2022-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11499178-B2 | Labeling method for nucleic acid | DNTT, RNMT, RNGTT | P2RY12 4535/4885P2RY1 4291/4885PRMT6 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.